Fluorescent-guided robotic lung surgery for early lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Your lung tumor must be smaller than 3 centimeters
- You must have stage 1 non-small cell lung cancer
- Your CT scan must show the tumor is limited to one lung segment (so segment removal is appropriate)
- You must not be allergic to the study dye or related iodine-based substances (ICG, sodium iodide/iodine)
- If you can get pregnant, you must use reliable birth control; pregnancy or breastfeeding is not allowed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This study tests a new way to help surgeons remove lung cancer more precisely using virtual reality and a special dye. It might help ensure the cancer is fully removed while saving as much healthy lung as possible.
This trial tests whether using special near-infrared imaging can help surgeons better guide lung tumor removal during minimally invasive or open chest surgery. It may improve how accurately the surgical area is identified during the operation.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
This trial tests whether using a special dye (called indocyanine green) during a minimally invasive laparoscopic surgery can help doctors see lymph nodes and cancer more clearly in patients with upper stomach cancer. The goal is to improve the precision of the surgery and possibly lead to better outcomes.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.